SOSV
SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
PONS is a machine learning approach for automatic identification of ultrasound (US) scans that have important anatomical brain features, and extraction of regions from the identified US scans that contain important anatomical brain features. The US probes and tech haven't changed too much for the last 25 years. PONS's target is to create a wearable US device that can learn and help first responders and ambulance doctors on pre-diagnostics on the way to the hospital or on difficult circumstances on the field. Pons develops a machine learning software that converts traditional ultrasound systems and devices into smart and AI-driven diagnostics and non-robotic navigation system focusing on brain problems and neurosurgeries.
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
Allozymes
Seed Round in 2021
Allozymes is a privately-held backing company that offers non-financial services.
Sophie Society increases sales conversion and traffic for small-medium e-commerce businesses on Amazon. Sophie Society is composed of top 1% marketplace experts in every domain from high-level strategy to Amazon advertising to content generation.
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
Allozymes
Seed Round in 2020
Allozymes is a privately-held backing company that offers non-financial services.
Unclaimed Property Consulting & Reporting LLC is an industry leader delivering value-added services and technology to companies facing non-compliance business risks and maintaining compliance with state unclaimed property laws. Their cost-effective compliance outsourcing solution provides you a hassle free and painless approach to unclaimed property compliance.
Paragon Flavors is a food company based in USA.
Portfolio.io allows you to create a portfolio of digital assets in under 60 seconds. No wallets. No exchanges. Zero fees.*
Diabeto, Inc. is a healthcare technology company based in Piscataway, New Jersey, focused on diabetes management solutions. Founded in 2012, the company offers a non-intrusive, Bluetooth-enabled device that wirelessly transmits glucose readings from a glucometer to a smartphone. This functionality is complemented by a smartphone application designed to analyze the data, thereby enhancing the management of diabetes for users. By leveraging mobile and web technologies, Diabeto's device facilitates the synchronization of glucometer readings, allowing users to store their information in the cloud and share it with healthcare practitioners. This approach aims to improve the health and well-being of individuals with diabetes while bridging the communication gap between patients and caregivers. As of September 2017, Diabeto operates as a subsidiary of Livongo Health, Inc.
Wine Sherpa is a mobile tool that personalizes and simplifies wine shopping and enhances wine enjoyment. Each user is paired with a live wine expert who makes recommendations, receives feedback, answers questions and curates orders. This one on one service ensures that purchases are tailored to the user's preferences, getting better wine in their glass. Orders are filled at local wine shops an can be conveniently picked up or delivered.